Page last updated: 2024-08-21

pyrazines and Cancer of the Urinary Tract

pyrazines has been researched along with Cancer of the Urinary Tract in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Alva, AS; Appleman, LJ; Bitman, B; Burke, JM; Cetnar, J; Chan, C; Fleming, MT; George, DJ; Hahn, NM; Harrison, MR; Izumi, R; Milowsky, MI; Mortazavi, A; Munugalavadla, V; O'Donnell, PH; Patel, P; Schmidt, EV; Shore, N; Sonpavde, GP; Staats, J; Weinhold, KJ; Zhang, T	1
Afqir, S; Belbaraka, R; Benjaafar, N; Elmajjaoui, S; Errihani, H; Ismaili, N; Tahri, A	1
Degendorfer, P; Gomez-Abuin, G; Moore, MJ; Pond, G; Stadler, WM; Winquist, E; Wright, J	1
Atkins, JN; Bajorin, DF; Halabi, S; Himelstein, AL; Hohl, RJ; Millard, F; Rosenberg, JE; Sanford, BL; Small, EJ	1

Trials

3 trial(s) available for pyrazines and Cancer of the Urinary Tract

Article	Year
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer. Cancer, 2020, 10-15, Volume: 126, Issue:20 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Metastasis; Pyrazines; Urologic Neoplasms	2020
A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia. Investigational new drugs, 2007, Volume: 25, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Pyrazines; Survival Analysis; Urologic Neoplasms; Urothelium	2007
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Transitional Cell; Disease Progression; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Middle Aged; Protease Inhibitors; Pyrazines; Salvage Therapy; Treatment Failure; Urologic Neoplasms	2008

Other Studies

1 other study(ies) available for pyrazines and Cancer of the Urinary Tract

Article	Year
[Urological cancers: ECCO/ESMO congress 2011]. Presse medicale (Paris, France : 1983), 2012, Volume: 41, Issue:12 Pt 1 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Hydroxamic Acids; Medical Oncology; Pyrazines; Societies, Medical; Sulfonamides; Sweden; Urologic Neoplasms	2012